Royalty Pharma Plc (RPRX)
63.86
+0.11
(+0.17%)
USD |
NASDAQ |
Oct 23, 16:00
63.84
-0.02
(-0.03%)
After-Hours: 20:00
Royalty Pharma Cash from Investing (Quarterly) : -216.51M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -216.51M |
| March 31, 2026 | -520.17M |
| December 31, 2025 | -852.80M |
| September 30, 2025 | -959.42M |
| June 30, 2025 | -370.15M |
| March 31, 2025 | 468.95M |
| December 31, 2024 | -507.58M |
| September 30, 2024 | -1.203B |
| June 30, 2024 | -895.95M |
| March 31, 2024 | -90.19M |
| December 31, 2023 | -998.75M |
| September 30, 2023 | -453.37M |
| June 30, 2023 | -62.40M |
| March 31, 2023 | -589.70M |
| December 31, 2022 | 416.09M |
| Date | Value |
|---|---|
| September 30, 2022 | -1.423B |
| June 30, 2022 | -28.40M |
| March 31, 2022 | 13.36M |
| December 31, 2021 | -525.04M |
| September 30, 2021 | -840.55M |
| June 30, 2021 | 136.08M |
| March 31, 2021 | -597.08M |
| December 31, 2020 | -764.96M |
| September 30, 2020 | -1.040B |
| June 30, 2020 | -260.38M |
| March 31, 2020 | -641.92M |
| December 31, 2019 | -25.33M |
| September 30, 2019 | -615.27M |
| June 30, 2019 | -158.36M |
| March 31, 2019 | -1.317B |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co., Inc. | -5.602B |
| Johnson & Johnson | -2.709B |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
| Veru, Inc. | 1.802M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 715.25M |
| Cash from Financing (Quarterly) | -273.15M |
| Free Cash Flow | 612.50M |
| Free Cash Flow Per Share (Quarterly) | 0.8336 |
| Free Cash Flow to Equity (Quarterly) | 458.78M |
| Free Cash Flow to Firm (Quarterly) | 557.84M |
| Free Cash Flow Yield | 1.83% |